Pierre Gholam is a Gastroenterology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 48 publications with 1,413 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Ave
Cleveland, OH 441061716
Telephone
216-844-8500Provider last certified this registry record 15 Jan 2021.
Industry payments
30 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year2025154 payments$188,059openpaymentsdata.cms.gov ↗
- Ipsen Biopharmaceuticals, IncProgram year202549 payments$91,672openpaymentsdata.cms.gov ↗
- Novo Nordisk IncProgram year202522 payments$42,565openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
41.3%Rifamycin Antibacterial9.3%Xifaxan100%Part D≥12 patientsCorticosteroid8.5%Prednisone100%Part D≥13 patients+ 7 more classes in this area
Cardiovascular
31.5%Beta blocker11.6%Carvedilol100%Part D≥22 patientsAldosterone antagonist (MRA)10.9%Spironolactone85%Eplerenone15%Part D<11 patients+ 1 more class in this area
Anti-infectives
13.4%Nucleoside and nucleotide reverse transcriptase inhibitors10.8%Vemlidy89%Tenofovir Disoproxil Fumarate11%Part D<11 patientsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1.4%Entecavir100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2009–2013 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Joseph Sabik, MD
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”